These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

372 related articles for article (PubMed ID: 31055730)

  • 21. How to identify tremor dominant and postural instability/gait difficulty groups with the movement disorder society unified Parkinson's disease rating scale: comparison with the unified Parkinson's disease rating scale.
    Stebbins GT; Goetz CG; Burn DJ; Jankovic J; Khoo TK; Tilley BC
    Mov Disord; 2013 May; 28(5):668-70. PubMed ID: 23408503
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Homocysteine is not associated with global motor or cognitive measures in nondemented older Parkinson's disease patients.
    Camicioli RM; Bouchard TP; Somerville MJ
    Mov Disord; 2009 Jan; 24(2):176-82. PubMed ID: 18951534
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The influence of white matter hyperintensity on cognitive impairment in Parkinson's disease.
    Liu H; Deng B; Xie F; Yang X; Xie Z; Chen Y; Yang Z; Huang X; Zhu S; Wang Q
    Ann Clin Transl Neurol; 2021 Sep; 8(9):1917-1934. PubMed ID: 34310081
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Analysis of gait characteristics and related factors in patients with Parkinson's disease based on wearable devices.
    Tang H; Liao X; Yao J; Xing Y; Zhao X; Cheng W; Gu T; Huang Y; Xu G; Luan P; Tian J; Li G
    Brain Behav; 2024 Apr; 14(4):e3440. PubMed ID: 38538928
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Greater loss of white matter integrity in postural instability and gait difficulty subtype of Parkinson's disease.
    Gu Q; Huang P; Xuan M; Xu X; Li D; Sun J; Yu H; Wang C; Luo W; Zhang M
    Can J Neurol Sci; 2014 Nov; 41(6):763-8. PubMed ID: 25377626
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Plasma homocysteine, folate and vitamin B12 levels in Parkinson's disease in China: A meta-analysis.
    Dong B; Wu R
    Clin Neurol Neurosurg; 2020 Jan; 188():105587. PubMed ID: 31733593
    [TBL] [Abstract][Full Text] [Related]  

  • 27. White matter hyperintensities in cognitive impairment with Lewy body disease: a multicentre study.
    Gan J; Shi Z; Liu S; Li X; Liu Y; Zhu H; Shen L; Zhang G; Lu H; Gang B; Chen Z; Ji Y
    Eur J Neurol; 2023 Dec; 30(12):3711-3721. PubMed ID: 37500565
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Periventricular white matter hyperintensity burden and cognitive impairment in early Parkinson's disease.
    Huang X; Wen MC; Ng SY; Hartono S; Chia NS; Choi X; Tay KY; Au WL; Chan LL; Tan EK; Tan LC
    Eur J Neurol; 2020 Jun; 27(6):959-966. PubMed ID: 32124496
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Reorganization of structural brain networks in Parkinson's disease with postural instability/gait difficulty.
    Li Z; Liu J; Miao X; Ge S; Shen J; Jin S; Gu Z; Jia Y; Zhang K; Wang J; Wang M
    Neurosci Lett; 2024 Mar; 827():137736. PubMed ID: 38513936
    [TBL] [Abstract][Full Text] [Related]  

  • 30. White matter hyperintensities are linked to future cognitive decline in de novo Parkinson's disease patients.
    Dadar M; Zeighami Y; Yau Y; Fereshtehnejad SM; Maranzano J; Postuma RB; Dagher A; Collins DL
    Neuroimage Clin; 2018; 20():892-900. PubMed ID: 30292088
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Homocysteine and cognitive impairment in Parkinson's disease: a biochemical, neuroimaging, and genetic study.
    Rodriguez-Oroz MC; Lage PM; Sanchez-Mut J; Lamet I; Pagonabarraga J; Toledo JB; García-Garcia D; Clavero P; Samaranch L; Irurzun C; Matsubara JM; Irigoien J; Bescos E; Kulisevsky J; Pérez-Tur J; Obeso JA
    Mov Disord; 2009 Jul; 24(10):1437-44. PubMed ID: 19452554
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cerebral Microbleeds are Associated with Postural Instability and Gait Disturbance Subtype in People with Parkinson's Disease.
    Chiu WT; Chan L; Wu D; Ko TH; Chen DY; Hong CT
    Eur Neurol; 2018; 80(5-6):335-340. PubMed ID: 30928974
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cerebrospinal fluid amyloid-β and phenotypic heterogeneity in de novo Parkinson's disease.
    Alves G; Pedersen KF; Bloem BR; Blennow K; Zetterberg H; Borm GF; Dalaker TO; Beyer MK; Aarsland D; Andreasson U; Lange J; Tysnes OB; Zivadinov R; Larsen JP
    J Neurol Neurosurg Psychiatry; 2013 May; 84(5):537-43. PubMed ID: 23117496
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Homocysteine Level Is Associated with White Matter Hyperintensity Locations in Patients with Acute Ischemic Stroke.
    Gao Y; Wei S; Song B; Qin J; Fang H; Ji Y; Zhang R; Sun S; Xu Y
    PLoS One; 2015; 10(12):e0144431. PubMed ID: 26641086
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Longitudinal White Matter Damage Evolution in Parkinson's Disease.
    Scamarcia PG; Agosta F; Spinelli EG; Basaia S; Stojković T; Stankovic I; Sarasso E; Canu E; Markovic V; Petrović I; Stefanova E; Pagani E; Kostic VS; Filippi M
    Mov Disord; 2022 Feb; 37(2):315-324. PubMed ID: 34806799
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Differentiating Parkinson's disease motor subtypes: A radiomics analysis based on deep gray nuclear lesion and white matter.
    Sun D; Wu X; Xia Y; Wu F; Geng Y; Zhong W; Zhang W; Guo D; Li C
    Neurosci Lett; 2021 Aug; 760():136083. PubMed ID: 34174346
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cognitive and motor correlates of grey and white matter pathology in Parkinson's disease.
    Dadar M; Gee M; Shuaib A; Duchesne S; Camicioli R
    Neuroimage Clin; 2020; 27():102353. PubMed ID: 32745994
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dual-task clinical and functional MRI correlates in Parkinson's disease with postural instability and gait disorders.
    Sarasso E; Gardoni A; Piramide N; Volontè MA; Canu E; Tettamanti A; Filippi M; Agosta F
    Parkinsonism Relat Disord; 2021 Oct; 91():88-95. PubMed ID: 34547654
    [TBL] [Abstract][Full Text] [Related]  

  • 39. β-Amyloid and postural instability and gait difficulty in Parkinson's disease at risk for dementia.
    Müller ML; Frey KA; Petrou M; Kotagal V; Koeppe RA; Albin RL; Bohnen NI
    Mov Disord; 2013 Mar; 28(3):296-301. PubMed ID: 23239424
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Association between homocysteine and third ventricle dilatation, mesencephalic area atrophy in Parkinson's disease with cognitive impairment.
    Fu XY; Zhang YC; Ding CW; Yang M; Song X; Wang CS; Chen XF; Zhang Y; Sheng YJ; Mao P; Mao CJ; Liu CF
    J Clin Neurosci; 2021 Aug; 90():273-278. PubMed ID: 34275563
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.